Study of a decision tool for endometrial cancer prevention
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is developing a tool to help women decide if using a hormone-releasing intrauterine device (IUD) is right for them to lower their risk of endometrial cancer. Researchers are interviewing women at different risk levels and healthcare providers to make the tool useful and easy to understand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You speak and read English or Spanish
- You have not gone through menopause
- You have never had endometrial cancer or a precancerous condition called complex atypical hyperplasia
- You are able to take part in an interview
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is developing a tool to help women with endometrial cancer better understand their diagnosis and treatment options. If you join, you will help shape this educational resource for future patients.
This study talks to women about their experience with endometrial cancer or related conditions to understand what might increase risk and how to prevent it. It includes women with and without a diagnosis so researchers can compare perspectives.
This study looks at whether a hormone-releasing IUD (LNG-IUS) can treat early-stage endometrial cancer or very early abnormal cell growth while helping you keep the option for future pregnancy. It aims to see how well the treatment works and how it affects fertility-related outcomes.
This study uses a risk model to detect endometrial cancer in people with unexplained abnormal uterine bleeding. It aims to find better ways to identify cancer early without relying only on invasive biopsies.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This study looks at how people with endometrial cancer manage their care and treatment. It aims to understand your experiences to help improve support for others.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.